HLA Typing Transplant Market 2022 Key Factors Major Drivers and Procurement Intelligence
The report "HLA
Typing for Transplant Market by Technology (PCR (SSO, SSP, Real Time),
Sequencing (NGS, Sanger)), Product (Instrument, Reagent, Software), Application
(Chimerism, Antibody Screening), End User (Hospital, Diagnolab, Academia) -
Global Forecast to 2025", is expected to reach USD 968 million by 2025
from USD 656 million in 2019, at a CAGR of 6.7%
The demand for transplant diagnostic products for HLA typing
is expected to grow mainly due to factors such as technological advancements,
the growing number of diagnostic centers & hospitals, increased
applications in patient profiling, and rising public-private investments to support
product development. These factors have prompted market players to improve and
strengthen their current manufacturing and distribution capabilities—especially
in emerging markets, which are expected to witness the highest growth.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742
Based on the product, the reagents & consumables segment
held the largest share of the market
Based on the product, the HLA typing for the transplants
market is segmented into reagents & consumables, instruments, and software
& services. The reagents & consumables segment held the largest share of
the global HLA typing for the transplants market
Based on technology, the molecular assays segment is
expected to witness the highest growth during the forecast period.
Based on technology, the HLA typing for the transplants
market is segmented into molecular assay and non-molecular assay technology.
The molecular assay technology segment is expected to register the highest CAGR
during the forecast period. Factors such as its varied applications in patient
profiling, rising public-private investments to support product development,
and increasing clinical evidence of its efficacy are driving the growth of this
segment.
Based on the application, the diagnostic application
segment accounted for the largest share of this market
Based on the application, the HLA typing for the transplants
market is categorized into diagnostic and research applications. Diagnostic
applications accounted for the largest share of the HLA typing for the
transplants market.
North America accounted for the largest share of the HLA
typing for transplants market
North America accounted for the largest share of the HLA
typing for the transplants market in 2019, followed by Europe. This can
primarily be attributed to the continuous commercialization of innovative
transplant diagnostic products (includes HLA typing) coupled with ongoing
advancements in the field of genomics and proteomics, recent discovery genetic
biomarkers & their clinical role in immunoassay testing, and the increasing
prevalence of chronic and communicable diseases.
Get 10% Customization on this Research Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=96374742
Key
Market Players
Some of the prominent players in the HLA typing for the
transplants market are Thermo Fisher Scientific, Inc. (US), QIAGEN N.V.
(Netherlands), Illumina (US), CareDx, Inc. (US), and Immucor, Inc. (US). Others
are Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland),
Hologic, Inc. (US), Luminex (US), Biofortuna (UK), Takara Bio (Japan), Omixon
(Hungary), Becton, Dickinson and Company (US), Fujirebio, Inc. (Japan), and TBG
Diagnostics Ltd. (Australia)
This research report categorizes the HLA typing for
transplants market into the following segments and subsegments:
By Technology
- Molecular
Assay Technologies
- Non-molecular
Assay Technologies
By Product &
Service
- Reagents
& Consumables
- Instruments
- Software
& Services
By Application
- Diagnostic
Applications
- Research
Applications
By End-User
- Independent
Reference Laboratories
- Hospitals
& Transplant Centers
- Research
Laboratories & Academic Institutes
By Region
- North
America
- Europe
- Asia Pacific
- Latin
America
- Middle
East and Africa
Get Special Pricing on Bundle Reports:
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=96374742
Don’t miss out on business opportunities in HLA Typing
for Transplant Market. Speak to our analyst and gain crucial industry insights
that will help your business grow.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on
30,000 high growth niche opportunities/threats which will impact 70% to 80% of
worldwide companies’ revenues. Currently servicing 7500 customers worldwide
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top
officers across eight industries worldwide approach MarketsandMarkets™ for
their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to identify
new opportunities, identify most important customers, write "Attack, avoid
and defend" strategies, identify sources of incremental revenues for both
the company and its competitors. MarketsandMarkets™ now coming up with 1,500
MicroQuadrants (Positioning top players across leaders, emerging companies,
innovators, strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this
year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets’s flagship competitive intelligence and
market research platform, "Knowledgestore" connects over 200,000
markets and entire value chains for deeper understanding of the unmet insights
along with market sizing and forecasts of niche markets.
Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Comments
Post a Comment